Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lukasz Skalski"'
Autor:
Marek Drozdzik, Joanna Lapczuk-Romanska, Christoph Wenzel, Lukasz Skalski, Sylwia Szeląg-Pieniek, Mariola Post, Arkadiusz Parus, Marta Syczewska, Mateusz Kurzawski, Stefan Oswald
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4543 (2023)
Hepatic drug metabolizing enzymes (DMEs), whose activity may be affected by liver diseases, are major determinants of drug pharmacokinetics. Hepatitis C liver samples in different functional states, i.e., the Child–Pugh class A (n = 30), B (n = 21)
Externí odkaz:
https://doaj.org/article/7afe6b9a50bc4df0bc1e924080b91291
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Piotr Koscinski, Adam Bujnowski, Lukasz Skalski, Anna Skurczynska, Arkadiusz Palinski, Jerzy Wtorek
Publikováno v:
Journal of Physics: Conference Series. 434:012035
A practical application of a bioimpedance technique for a detection of a bathing person is presented in the paper. It addresses the possibility of supervising people in the bathtub without voiding of their intimacy. The measurement system installed i
Autor:
Marek Droździk, Joanna Lapczuk-Romanska, Christoph Wenzel, Łukasz Skalski, Sylwia Szeląg-Pieniek, Mariola Post, Marta Syczewska, Mateusz Kurzawski, Stefan Oswald
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 14, p 7947 (2022)
Transmembrane drug transport in hepatocytes is one of the major determinants of drug pharmacokinetics. In the present study, ABC transporters (P-gp, MRP1, MRP2, MRP3, MRP4, BCRP, and BSEP) and SLC transporters (MCT1, NTCP, OAT2, OATP1B1, OATP1B3, OAT
Externí odkaz:
https://doaj.org/article/fa8c5606dbee4c3abc2d7ebfa2367d31
Autor:
Marek Drozdzik, Joanna Lapczuk-Romanska, Christoph Wenzel, Sylwia Szelag-Pieniek, Mariola Post, Łukasz Skalski, Mateusz Kurzawski, Stefan Oswald
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1334 (2021)
Hepatic drug metabolizing enzymes (DMEs) markedly affect drug pharmacokinetics. Because liver diseases may alter enzymatic function and in turn drug handling and clinical efficacy, we investigated DMEs expression in dependence on liver pathology and
Externí odkaz:
https://doaj.org/article/5d8fca0e121047dd9394a9be7c6ec67c
Autor:
Magdalena Perużyńska, Aleksandra Borzyszkowska-Ledwig, Jacek G. Sośnicki, Łukasz Struk, Tomasz J. Idzik, Gabriela Maciejewska, Łukasz Skalski, Katarzyna Piotrowska, Paweł Łukasik, Marek Droździk, Mateusz Kurzawski
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 5, p 2462 (2021)
Most anticancer drugs target mitosis as the most crucial and fragile period of rapidly dividing cancer cells. However the limitations of classical chemotherapeutics drive the search for new more effective and selective compounds. For this purpose str
Externí odkaz:
https://doaj.org/article/f0dbc27f559c424a8a0e26d4adbebc45